Retrovirus News and Research

RSS

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Viral Genetics announced today that the results of a clinical trial of its investigational therapy for HIV infection, VGV-1, were recently published in a peer reviewed journal, HIV & AIDS Review.

29 Nov 2004

Long-term safety of transplanted pig cells to humans confirmed

Living Cell Technologies Limited has published a paper in the November issue of the Journal of Clinical Microbiology which demonstrates the long-term safety of transplanted insulin-producing pig islets in people with type 1 diabetes.

4 Nov 2004

Researchers investigate whether simian foamy virus can be transmitted through blood transfusion

Using an animal model, researchers demonstrated that simian foamy virus can be transmitted through blood from one non-human primate to another. Although this virus is not known to cause disease or health conditions in people or animals, this new research identifies an emerging issue related to the safety and adequacy of Canada's blood supply.

25 Oct 2004

First whole-genome survey of where three commonly used retroviruses into human DNA

Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients.

22 Aug 2004

Diseases are being neglected in wake of HIV/AIDS, TB and Malaria

Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.

29 Jul 2004

Researchers discover a mechanism that blocks replication of a retrovirus

A team of scientists led by University of Georgia researchers has discovered a naturally occurring mechanism that blocks a critical step late in retrovirus replication.

21 Jul 2004

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Researchers at Johns Hopkins and University of Witwatersrand, South Africa, have determined that the actual average cost for providing primary care to an HIV-infected patient is $30 USD per visit.

11 Jul 2004

Cheap AIDS drugs may help prevent HIV in babies in Thailand

Aids is one of the principal causes of infant mortality in many developing countries. Viral transmission takes place during pregnancy (in utero), at the moment of childbirth or even during breastfeeding.

10 Jul 2004

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Plans for advocacy, activism and protests throughout the weeklong AIDS conference to highlight the pressing need for increased access to life-saving anti-retroviral therapy (ARV) worldwide.

8 Jul 2004

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

Researchers at the Institute of Human Virology have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods.

15 Jun 2004

Fighting in the eastern Democratic Republic of Congo will affect HIV patients

Fighting in the eastern Democratic Republic of Congo (DRC) town of Bukavu - adjacent to the border with Rwanda - near the end of May has caused an MSF team there to seek refuge in the nearby UN compound.

1 Jun 2004

Bacteria found in the mouth can block the HIV virus

Certain strains of bacteria that occur naturally in the human mouth can snare the HIV virus and even cells it has infected, according to researchers at the University of Illinois at Chicago College of Dentistry. They report their findings today at the 104th General Meeting of the American Society for Microbiology.

25 May 2004

UN round table looks at rapid spread of HIV/AIDS in prisons

The rapid spread of HIV/AIDS in prisons, and practical measures to curb the spread of the disease in this section of society was the subject of a round table organized today by the United Nations Office on Drugs and Crime (UNODC) and attended by high-level international experts.

17 May 2004

Trial of antibody for HIV Infection

Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).

5 May 2004

Jefferson scientists learn how HIV causes dementia

Ever since the AIDS epidemic began more than two decades ago, scientists have been trying to understand why as many as one-quarter of those infected with HIV develop dementia.

19 Apr 2004

Genetic trick makes gene therapy vectors more versatile

A genetic trick used by viruses to replicate themselves has been adapted for laboratory use to build complex protein structures required by immune system cells, according to investigators at St. Jude Children’s Research Hospital.

7 Apr 2004

Researchers turn off individual human genes to study their function

Researchers have produced vast libraries of short segments of ribonucleic acid (RNA) that can be used to turn off individual human and mouse genes to study their function. The libraries will be made widely available to laboratories studying human biology and disease. The researchers are optimistic that the libraries will become a powerful research tool for gene analysis and discovery.

25 Mar 2004

£5m for HIV/AIDS trial involving HIV patients in London, Moscow, South Africa and Australia

A joint Oxford University/Imperial College research programme into HIV/AIDS has received £5 million support from the Wellcome Trust to carry out a drug trial involving HIV patients in London, Moscow, South Africa and Australia.

24 Mar 2004